Wolverine Trading’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$225K Sell
12,000
-14,100
-54% -$227K ﹤0.01% 4787
2025
Q2
$348K Buy
26,100
+15,700
+151% +$186K ﹤0.01% 3310
2025
Q1
$120K Sell
10,400
-3,700
-26% -$58.7K ﹤0.01% 4165
2024
Q4
$234K Buy
+14,100
New +$265K ﹤0.01% 4320
2024
Q1
Sell
-15,300
Closed -$482K 4458
2023
Q4
$482K Buy
15,300
+2,600
+20% +$61.8K ﹤0.01% 2987
2023
Q3
$324K Sell
12,700
-6,700
-35% -$206K ﹤0.01% 3208
2023
Q2
$516K Buy
+19,400
New +$528K ﹤0.01% 2571
2021
Q2
Sell
-13,000
Closed -$504K 5878
2021
Q1
$504K Sell
13,000
-15,200
-54% -$906K ﹤0.01% 3686
2020
Q4
$1.32M Buy
28,200
+13,700
+94% +$928K ﹤0.01% 2101
2020
Q3
$620K Buy
14,500
+6,700
+86% +$333K ﹤0.01% 2577
2020
Q2
$366K Sell
7,800
-4,900
-39% -$169K ﹤0.01% 3093
2020
Q1
$168K Buy
+12,700
New +$163K ﹤0.01% 3779
2017
Q2
Sell
-1,629
Closed -$13K 4234
2017
Q1
$13K Buy
+1,629
New +$15.1K ﹤0.01% 4115
2016
Q4
Sell
-5,171
Closed -$91K 4409
2016
Q3
$91K Sell
5,171
-1,143
-18% -$36.9K ﹤0.01% 4230
2016
Q2
$192K Buy
+6,314
New +$199K ﹤0.01% 3309

Other funds holding ARCT